Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

25%

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(2)

Detailed Status

unknown2

Completed1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

completed125%

not_yet_recruiting125%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

not_yet_recruiting

Causes of Spinal Failure in Cesarean Section

NCT06973486

completedphase_2

Ocytocine and Cerebral Activation in Relation With Attachement

NCT02847143

unknownnot_applicable

Exposures to Perinatal Adverse Experiences: Multimodal Omics Signature of Stress Vulnerability and Resilience and Preventive Strategies

NCT05951738

unknownnot_applicable

Inflammatory Markers and Resistant Depression

NCT02847533

Clinical Trials (4)

Showing 4 of 4 trials

NCT06973486

Causes of Spinal Failure in Cesarean Section

Not Yet Recruiting

NCT02847143Phase 2

Ocytocine and Cerebral Activation in Relation With Attachement

Completed

NCT05951738Not Applicable

Exposures to Perinatal Adverse Experiences: Multimodal Omics Signature of Stress Vulnerability and Resilience and Preventive Strategies

Unknown

NCT02847533Not Applicable

Inflammatory Markers and Resistant Depression

Unknown

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4